| 英文别名 |
Canertinib dihydrochloride;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride;Canertinib (dihydrochloride);Canertinib (hydrochloride);Canertinib 2HCl;Canertinib, Dihydrochloride Salt (Canertinib DiHCl, CI-1033,CI 1033, PD-183805, PD-0183805);Canertinib.2HCL;CI1033;Canertinib;Canertinib HCl;CI103;CI1033 dihydrochloride;CI-1033 dihydrochloride;PD183805 dihydrochloride;PD-183805 dihydrochloride;N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride;PD183805;CI 1033;PD 183805;Canertinib dihydrochloride [USAN];ICJ93X8X90;N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide dihydrochloride;Canertinib dihydrochloride (USAN);N-(4-(3-ch;2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-, dihydrochloride;AKOS015924656;N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride;PD-0183805-002B;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride;CANERTINIB DIHYDROCHLORIDE [MI];FT-0724289;D03350;AS-75065;CI-1033, >=98% (HPLC);SCHEMBL2052123;Q-200787;N-(4-(3-chloro-4-fluorophenyl)amino)-7-(3-morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride;289499-45-2 (HCl);Q-101362;AM20090674;Q27280663;MFCD09954112;UNII-ICJ93X8X90;2-Propenamide, N-(4-((3-chloro-4-fluorophenyl) amino)-7-(3-(4-morpholinyl) propoxy)-6-quinazolinyl)-, dihydrochloride;HMS3295E05;PD-0183805;CANERTINIB DIHYDROCHLORIDE [WHO-DD];CI-1033;SN-26606;2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL) AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-, DIHYDROCHLORIDE;CANERTINIB HYDROCHLORIDE;A19399;N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride;EN300-19659633;BCP01902;DTXSID80183143;289499-45-2;S0711;CI-1033 dihydrochloride;PD-183805 dihydrochloride;AC-2414;N-[4-(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-yl)propoxy]quinazolin-6-yl]prop-2-enamide dihydrochloride;CI-103;CS-0263;CHEMBL545315;N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide dihydrochloride;N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-2-PROPENAMIDE DIHYDROCHLORIDE;Canertinib dihydrochloride salt;N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride;HY-10367A;PD-183805;Canertinib dihydrochloride?;2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2) |
微信公众号
客服
N)O)
